UBS Group
BFRI icon

UBS Group’s Biofrontera BFRI Stock Holding History

UBS Group’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.5K Buy
18,518
+16,978
+1,102% +$16.8K ﹤0.01% 8238
2026
Q1 		$1.25K Sell
1,540
-8,825
-85% -$7.6K ﹤0.01% 9573
2025
Q4 		$5.91K Buy
10,365
+9,377
+949% +$8.47K ﹤0.01% 8611
2025
Q3 		$973 Sell
988
-13
-1% -$12 ﹤0.01% 9474
2025
Q2 		$713 Buy
1,001
+970
+3,129% +$678 ﹤0.01% 9757
2025
Q1 		$25 Sell
31
-14,042
-100% -$14.4K ﹤0.01% 10069
2024
Q4 		$15.3K Buy
14,073
+10,974
+354% +$10.4K ﹤0.01% 8050
2024
Q3 		$4.12K Sell
3,099
-6,918
-69% -$7.92K ﹤0.01% 8181
2024
Q2 		$8.99K Buy
+10,017
New +$13.8K ﹤0.01% 7766
2023
Q4 		– Sell
-1
Closed -$9 – 9315
2023
Q3 		$9 Buy
+1
New +$10 ﹤0.01% 9225
2023
Q2 		– Sell
-61
Closed -$739 – 8928
2023
Q1 		$739 Buy
+61
New +$951 ﹤0.01% 8919
2022
Q4 		– Sell
-237
Closed -$5K – 10731
2022
Q3 		$5K Buy
+237
New +$6.47K ﹤0.01% 9167

Other funds holding BFRI

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

UBS Group's BFRI Position: Q2 2026 in Review

UBS Group increased its Biofrontera (BFRI) stake by 1,102% in Q2 2026, buying an estimated $16.8K and bringing the position to 18,518 shares worth $17.5K. The position accounts for ﹤0.01% of the portfolio, ranked #8238.

UBS Group first reported a position in BFRI in Q3 2022 and has held it in 12 quarters since. 19 funds tracked by Wall St. Rank hold BFRI as of Q2 2026.

  • UBS Group held 18,518 shares of Biofrontera worth $17.5K as of Q2 2026.
  • UBS Group bought 16,978 Biofrontera shares in Q2 2026, an estimated $16.8K.
  • Biofrontera made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8238 holding.
  • UBS Group first reported a position in Biofrontera in Q3 2022 and has held it in 12 quarters since.
  • 19 funds tracked by Wall St. Rank held Biofrontera as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.